Phibro Animal Health (NASDAQ:PAHC) Downgraded to "Hold" Rating by StockNews.com

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) was downgraded by equities researchers at StockNews.com from a "buy" rating to a "hold" rating in a research report issued on Friday.

A number of other equities analysts have also issued reports on PAHC. Barclays boosted their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a research report on Monday, February 10th. Morgan Stanley boosted their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an "equal weight" rating in a research report on Tuesday, December 17th. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $21.00.

Phibro Animal Health Stock Performance

Shares of NASDAQ:PAHC traded up $0.33 during trading on Friday, reaching $23.64. The stock had a trading volume of 339,958 shares, compared to its average volume of 253,645. Phibro Animal Health has a 52 week low of $11.98 and a 52 week high of $26.55. The firm has a market capitalization of $957.49 million, a price-to-earnings ratio of 49.25, a P/E/G ratio of 0.45 and a beta of 0.58. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. The stock has a fifty day simple moving average of $22.47 and a two-hundred day simple moving average of $22.51.

Remove Ads

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, beating analysts' consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. As a group, analysts anticipate that Phibro Animal Health will post 1.95 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Phibro Animal Health

A number of institutional investors have recently bought and sold shares of PAHC. Thrivent Financial for Lutherans boosted its stake in Phibro Animal Health by 23.1% during the third quarter. Thrivent Financial for Lutherans now owns 20,791 shares of the company's stock worth $468,000 after buying an additional 3,907 shares in the last quarter. Segall Bryant & Hamill LLC boosted its stake in shares of Phibro Animal Health by 1.7% in the 3rd quarter. Segall Bryant & Hamill LLC now owns 174,569 shares of the company's stock valued at $3,931,000 after purchasing an additional 2,971 shares in the last quarter. Algert Global LLC boosted its stake in shares of Phibro Animal Health by 521.1% in the 3rd quarter. Algert Global LLC now owns 71,335 shares of the company's stock valued at $1,606,000 after purchasing an additional 59,850 shares in the last quarter. FMR LLC boosted its stake in shares of Phibro Animal Health by 22.7% in the 3rd quarter. FMR LLC now owns 39,310 shares of the company's stock valued at $885,000 after purchasing an additional 7,270 shares in the last quarter. Finally, Quantbot Technologies LP acquired a new stake in shares of Phibro Animal Health in the 3rd quarter valued at $70,000. Institutional investors and hedge funds own 99.34% of the company's stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.